Proinflammatory cytokine genes and their polymorphic variants: clinical and laboratory profiles in the Federal Firefighting Service employees of the EMERCOM of Russia

Relevance. Genetic determinants of multifactorial diseases are critical for assessing the risk of genetic diseases and their prevention, especially among the workforce exposed to industry-related dangerous and aggressive occupational factors. Firefighters perform combat service duties in extremely unfavorable industrial environments associated with occupational diseases. Respiratory diseases are among the pathologies with highest incidence rates in firefighters. In addition to environmental factors, the development of these diseases (especially bronchial asthma and chronic obstructive pulmonary disease) is largely driven by impaired immune system – one of the three critical regulatory systems involved in pathogenetic mechanisms of various diseases, including inflammatory diseases. Polymorphic gene variants of inflammatory mediators – in particular cytokine genes and their receptors – mediate the immune system activity and can impact its functionality, susceptibility, or resistance to disease development.

The objective is to analyze how interleukin 1β, 4, 6, 13, TNF and interleukin 6 receptor genes, as well as their polymorphic variants are associated with respiratory diseases and changes in the biomarker profiles showing immune response intensity in the employees of the Federal Firefighting Service of the EMERCOM of Russia.

 Methodology. Molecular genetic profiling and immunology tests were performed in 70 employees of the Federal Firefighting Service of the EMERCOM of Russia to analyze proinflammatory cytokine genes and their polymorphic variants. Real-timePCR was used to analyze the interleukin 1β, 4, 6, 13, TNF and interleukin-6 receptor genes and their polymorphic variants. Immunological examination evaluated the blood monocyte subpopulations and relative count of type 2 T-helper cells; flowcytometry and immunochemiluminescence assays were used to evaluate immune response biomarkers in peripheral blood and total immunoglobulin E (IgE) respectively.

Results and discussion. The analysis provides evidence that minor alleles of most polymorphic cytokine genes are associated with a proinflammatory phenotype, which is especially apparent for genotypes comprising several minor alleles. Allele A at rs1 800 629 polymorphic TNF gene exposed a direct correlation with respiratory diseases, as well as with increased monocyte differentiation. Allele T of IL4 rs2243250 gene and allele A of IL1β rs16944 gene were associated with increased proinflammatory monocyte count. Elevated count of type 2 T-helper mediators of humoral response, especially of allergicorigin, was observed in individuals with C/C IL6 rs1 800 795 and G/G IL1β rs16944 genotype.

Conclusion. The obtained results suggest that evaluation of cytokine gene polymorphic variants is a promising strategy to predict the risk of respiratory diseases in firefighters. Prompt assessment of genetic predisposition to a proinflammatory phenotype paves the way towards prevention and early detection of inflammatory diseases in this cohort of workers.

1. Bychkova N.V. CD3+CD294+ T-limfocity 2-go tipa im munnogo otveta i ih rol’ v razvitii allergicheskogo vospalen ija [Cd3+cd294+t cells of the type 2 immune response: their role in allergic inflammation]. Medicinskaja immunologija [Medical Immunology (Russia)]. 2022; 24(5):935–946. DOI: 10.15789/1563-0625-CCO-2543. (In Russ.)

2. Bychkova N.V., Kalashnikova A.A., Kalinina N.M. Vlijanie professional’noj dejatel’nosti i kurenija na izmenenija immuno logicheskih pokazatelej u pozharnyh [The impact of occupational hazards and smoking on immunity parameters in firefighters] Mediko-biologicheskie i social’no-psihologicheskie problemy bezopasnosti v chrezvychajnyh situacijah [Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situ ations]. 2023; (3):72–80. DOI: 10.25016/2541-7487-2023-0-3-72-80. (In Russ.)

3. Viktorova T.V., Korytina G.F., Tselousova O.S. [et al.]. Analiz polimorfnyh lokusov genov sistemy proteoliza u bol’nyh s hronicheskoj obstruktivnoj bolezn’ju legkih [Analysis of pro teolysis gene polymorphic loci in chronic obstructive pulmo nary disease patients]. Medicinskij vestnik Bashkortostana [Bashkortostan Medical Journal]. 2012; 7(2):23–26. (In Russ.)

4. Kalashnikova A.A., Voroshilova T.M., Chinenova L.V. [et al.]. Subpopuljacii monocitov u zdorovyh lic i u pacientov s sep sisom [Monocyte subsets in healthy adults and sepsis patients]. Medicinskaja immunologija [Medical Immunology (Russia)]. 2018; 20(6):815–824. DOI: 10.15789/1563-0625-2018-6-815-824. (In Russ.)

5. Kozlov V.A. Ocherki o funkcional’noj nastroennosti im munnoj sistemy [Essays on the functional attunement of the im mune system]. Krasnojarsk. 2022. 250 p. (In Russ.)

6. Akkad D.A., Arning L., Ibrahim S.M. [et al]. Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels. Genes Immun. 2007; (8)703–706. DOI: 10.1038/sj.gene.6364429.

7. Ahmadi A., Ghaedi H., Salimian J. [et al]. Association between chronic obstructive pulmonary disease and interleukins gene variants: A systematic review and meta-analysis. Cytokine. 2019; 117: 65–71. DOI: 10.1016/jcyto.2019.02.003.

8. Aoki T., Hirota T., Tamari M. [et al]. An association between asthma and TNF-308G/A polymorphism: met analysis. J. Hum. Genet. 2006; 51(8):677–685. DOI: 10.1007/s10038-006-0007-3

9. Bernstein Z.J., Shenoy A., Chen A. [et al]. Engineering the IL-4/IL-13 axis for targeted immune modulation Immuno.l Rev. 2023; (7). DOI: 10.1111/imr.13230.

10. Bychkova N.V., Kalashnikova A.A., Kalinina N.M. T lymphocytes of the 2nd type of the immune response and their role in enhancing inflammation during the professional activities of firefighters. Medical Immunology (Russia). 2023; 25(4):741–746. DOI: 10.15789/1563-0625-TLO-2739

11. Chen Y., Griffiths C.E.M., Bulfone-Paus S. Exploring mast cell-CD8 T cell interactions in inflammatory ski diseases. Int. J. Mo.l Sci. 2023; 24(2):1564. DOI: 10.3390/ijms24021564.

12. Demenais F., Margaritte-Jeannin P., Barnes K.C. [et al]. Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat. Genet. 2018; 50(1):42–53. DOI: 10.1038/s41588-017-0014-7

13. Du J.W., Xu Z.L., Xu Q.X. Interaction of interleukin 7 receptor (IL7R) and IL6 gene polymorphisms with smoking associated with susceptibility to asthma in Chinese Han adults. Immunol. Invest. 2022; 51(5):1364– 1371. DOI: 10.1080/08820139.2021.1941083.

14. Falfán-Valencia R ., Pavón-Romero G.F., Camarena A. [et al]. The IL1B-511 polymorphism (rs16944 AA genotype) is increased in aspirin-exacerbated respiratory disease in Mexican population. J. Allergy (Cairo). 2012; 741313. DOI: 10.1155/2012/741313.

15. Ferreira M.A., Matheson M.C., Duffy D.L. [et al]. Identification of IL6R and chromosome 11q13. 5 as risk loci for asthma. Lancet. 2011; 378(9795):1006–1014. DOI: 10.1016/S0140-6736(11)60874-X

16. Hinds D., McMahon G., Kiefer A. [et al]. A genome-wide association meta-analysis of self-reported al lergy identifies shared and allergy-specific susceptibility loci. Nat. Genet. 2013; (45):907–911. DOI: 10.1038/ng.2686.

17. Hameed I., Masoodi S.R., Malik P.A. [et al]. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression. Gene. 2018; (661):51–59. DOI: 10.1016/j.gene.2018.03.095.

18. Huyghe J., Priem D., Bertrand M.J.M. Cell death checkpoints in the TNF pathway. Trends Immunol. 2023; 44(8):628–643. DOI: 10.1016/j.it.2023.05.007.

19. Hwang I.R., Kodama T., Kikuchi S. [et al]. Effect of interleukin 1 polymorphisms on gastric mucosal inter leukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002; 123: 1793–1803. DOI: 10.1053/gast.2002.37043.

20. Iacoviello L., Di Castelnuovo A., Gattone M. [et al]. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimula tion in vitro. Arterioscler Thromb. Vasc. Biol. 2005; 25; 222–227. DOI: 10.1161/01.ATV.0000150039.60906.02.

21. Imani D., Eslami M.M., Anani-Sarab G. [et al]. Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: a meta-analysis based on 24 publications. BMC Med. Genet. 2020; 21:232. DOI: 10.1186/s12881-020-01169-w

22. Jimenez-Sousa M. A., Medrano L. M., Liu P. [et al.]. IL-1B rs16944 polymorphism is related to septic shock and death. Europ. J. Clin. Investigation. 2017; 47(1):53–62.

23. Johansson A., Rask-Andersen M., Karlsson T. [et al]. Genome-wide association analysis of 350 000 Cau- casians from the UK Biobank identifies novel loci for asthma, hay fever and eczema. Hum. Mol. Genet. 2019; 28(23):4022–4041. DOI: 10.1093/hmg/ddz175.

24. Kitaura H., Zhou P., Kim H.J. [et al]. M-CSF mediates TNF-induced inflammatory osteolysis. J. Clin. Invest. 2005; 115(12):3418–3427. DOI: 10.1172/JCI26132

25. Kousha A., Mahdavi Gorabi A., Forouzesh M. [et al.]. Interleukin 4 gene polymorphism (–589C/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies. BMC Immunol. 2020; 21(1):55 DOI: 10.1186/s12865-020-00384-7

26. Munthe-Kaas M.C., Carlsen K.L., Carlsen K.H. [et al]. HLA Dr-Dq haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy. Allergy. 2007; 62(9):991–998. DOI: 10.1111/j.1398-9995.2007.01377.x.

27. Nakae S., Komiyama Y., Yokoyama H[et al]. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int. Immunol. 2003; 15(4):483–90. DOI: 10.1093/intimm/dxg054.

28. Patel A.A., Zhang Y., Fullerton J.N. [et al]. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J. Exp. Med. 2017; 214(7):1913–1923. DOI: 10.1084/jem.20170355.

29. Rogo L.D., Rezaei F., Marashi S.M. [et al]. Seasonal influenza A/H3N2 virus infection and IL-1B, IL-10, IL- 17, and IL-28 polymorphisms in Iranian population. J. Med. Virol. 2016; 88; 2078–2084. DOI:10.1002/jmv.24572

30. Wang H.R., Wei S.Z., Song X.Y. [et al]. IL-1β and Allergy: Focusing on Its Role in Allergic Rhinitis. Mediators Inflamm. 2023; 1265449. DOI: 10.1155/2023/1265449.

31. Wu H., Romieu I., Sienra-Monge J.J. [et al]. Parental smoking modifies the relation between genetic vari ation in tumor necrosis factor-alpha (TNF) and childhood asthma. Environ. Health Perspect. 2007; 115(4):616- 622. DOI: 10.1289/ehp.9740.

32. Yang G., Chen J., Xu F., Bao Z. [et al]. Association between tumor necrosis factor-α rs1800629 polymor- phism and risk of asthma: a meta-analysis. PLoS One. 2014; 9(6):e99962. DOI: 10.1371/journal.pone.0099962

33. Yu S., Xue M., Yan Z. [et al]. Correlation between TNF-α -308 and +489 gene polymorphism and acute exacer bation of chronic obstructive pulmonary diseases. Biomed Res. Int. 2021: 6661281. DOI: 10.1155/2021/6661281.

34. Zakaria M., Beshir M., Hassan T. [et al]. Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogen esis and prognosis of childhood primary immune thrombocytopenia. Eur. J. Pediatr. 2023; 182(7):3129–3138. DOI: 10.1007/s00431-023-04945-x

35. Zhu N., Gong Y., Chen X.D. [et al]. Association between the polymorphisms of interleukin-4, the in terleukin-4 receptor gene and asthma. Chin. Med. J. (Engl). 2013; 126(15):2943–2951. DOI: 10.3760/cma.j.issn.0366-6999.20123060

36. Zhu Z., Zhu X., Liu C.L. [et al]. Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis. Eur. Respir. J. 2019; 54(6):1901507. DOI: 10.1183/13993003.01507-2019